2010
DOI: 10.1111/j.1471-0528.2010.02739.x
|View full text |Cite
|
Sign up to set email alerts
|

Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double‐blind randomised trial

Abstract: and seven platelet concentrates were administered. Cyklokapron, Sulprostone, Methergine and Eptacog alpha were also administered. After packing of the uterus with gauzes, the fascia was closed and the patient was transferred to the intensive care unit. At the intensive care unit, haemolysis occurred as a result of the transfusion of uncrossmatched blood and DIC, antibiotics were given and hypotensive periods were treated with noradrenaline. Computed tomography did not show any cerebral, pulmonary or abdominal … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
2
0

Year Published

2010
2010
2018
2018

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 2 publications
1
2
0
Order By: Relevance
“…In line with the existing literature, the maternal sFlt-1 level in the EO-PE group was significantly higher than LO-PE and control group, while the sFlt-1 levels in the LO-PE group were not different when compared with the control group (Table 2) (19)(20)(21). This finding is in accordance with previous studies, showing the placental involvement/lesion in EO-PE, being minimal or absent in LO-PE.…”
Section: Discussionsupporting
confidence: 92%
“…In line with the existing literature, the maternal sFlt-1 level in the EO-PE group was significantly higher than LO-PE and control group, while the sFlt-1 levels in the LO-PE group were not different when compared with the control group (Table 2) (19)(20)(21). This finding is in accordance with previous studies, showing the placental involvement/lesion in EO-PE, being minimal or absent in LO-PE.…”
Section: Discussionsupporting
confidence: 92%
“…In addition, we tested the effects of the oxytocin analog Butyryl-Tyr(Me)-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2 (Carbetocin, CBT) designed to resist enzymatic cleavage and thus improve the stability of oxytocin in the peripheral circulation. Carbetocin, which is approved for use in many countries outside the United States for the control of postpartum intrauterine hemorrhage (Page, 2010) has been shown to have a longer plasma half-life than oxytocin and longer duration of uterine myometrium contractions (Engstrom et al, 1998). In addition, carbetocin has been shown to modulate certain behaviors when administered peripherally in rats (Chaviaras et al, 2010; Klenerova et al, 2009a, b).…”
Section: Introductionmentioning
confidence: 99%
“…Sir, Although the study by Attilakos et al 1 suggests some benefit of carbetocin versus oxytocin, this has to be interpreted with great caution.…”
mentioning
confidence: 99%